Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), today announced the voting results from its Annual General Meeting (AGM) of Shareholders held on Tuesday, May 9, 2023.
KaliVir Immunotherapeutics, Inc. today announced the appointment of Grant McFadden , Ph.D., to its Board of Directors.
Bayer and Bicycle Therapeutics plc today announced that they have entered into a strategic collaboration agreement to discover, develop, manufacture, and commercialize Bicycle radioconjugates for multiple agreed upon oncology targets.
Kallyope , Inc. today announced that it has received $8.2 million from the Bill & Melinda Gates Foundation.
KBI Biopharma Appoints Marykay Marchigiani as Chief Financial Officer and Sigma Mostafa, Ph.D., as Chief Scientific Officer.
Korro Bio, a leading RNA editing company focused on the discovery and development of novel genetic medicines, today announced the appointment of Shelby Walker, JD, as Senior Vice President and General Counsel.
Korro Strengthens Leadership Team with Appointment of Shelby Walker as General Counsel Read More »
FSD Pharma Inc. today announced the completion of dosing the first cohort of patients in the Company’s Phase I clinical trial of Lucid-21-302 (“Lucid-MS”).
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced it will provide its inactivated COVID-19 vaccine, CoronaVac®, to self-paying groups in Hong Kong.
SINOVAC’s CoronaVac® Answers Hong Kong’s Need for Self-Pay COVID-19 Vaccines Read More »
Ribbon Biolabs, the DNA synthesis company, announced the appointment of Jodi Barrientos as Chief Business Officer.
Ribbon Biolabs Appoints Jodi Barrientos as Chief Business Officer Read More »
CTI BioPharma announced that it has entered into a definitive agreement under which Swedish Orphan Biovitrum AB, a global healthcare leader in hematology, immunology and specialty care, will acquire CTI for $9.10 per share of common stock in an all-cash transaction, representing an implied equity value of approximately $1.7 billion.
